Swedish Orphan Biovitrum
MA - WalthamBiotechnology
Focus: Swedish Orphan Biovitrum (Sobi) is a specialty biopharmaceutical company headquartered in Waltham, MA, focused on rare diseases, oncology, and immunology through biologic therapeutics. The company operates as a publicly traded entity with a portfolio heavily concentrated in established biologics.
Profile data last refreshed 6h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
92+33 this month
Hot — 76 jobs added in 30d
Net +33 (76 new, 43 removed). Aggressive expansion phase.
Should You Work at Swedish Orphan Biovitrum?
AI assessmentSobi offers stability for those seeking established product experience in rare diseases and immunology, but career trajectory depends heavily on pipeline advancement and mitigation of severe revenue concentration risk.
Why Work Here
- Strong rare disease and immunology franchise with approved, revenue-generating products (KINERET generating $28M in Part D spending) providing portfolio stability
Data completeness
6/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$28M Part DDeclining
LOE Approaching
Core revenue driver (99% of revenue) but facing imminent loss of exclusivity, making it the critical inflection point for company viability.
Help build intelligence for Swedish Orphan Biovitrum
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.